THE initial step in the interaction of cathecholamines with the myocardium involves their binding to specific receptor sites on the cell membrane (Maguire et al., 1977) . Changes in the numbers of these receptors and/or their affinities for agonists may alter myocardial responsiveness to adrenergic stimulation. Catecholamine effects on the myocardium may be modulated at the receptor level through two general mechanisms: (1) altered synthesis of receptor molecules in concert with or independent of generalized changes in protein synthesis, and (2) changes in the physicochemical properties of their microenvironment which affect their lateral movement within the membrane and result in "unmasking" of cryptic receptor sites. Both mechanisms may be involved in cardiac hypertrophy which is associated with changes in both responsiveness to catecholamines (Spann et al., 1967; Kunos et al., 1967; Kunos et al., 1978) and the number of /?-adrenergic receptors (Williams et al., 1977; Limas and Limas, 1978; Woodcock et al., 1979) .
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It is likely that changes in the chemical composition of myocardial cell membranes which occur in the course of hypertrophy, determine-in part-the numbers and affinities of yS-adrenergic receptors. We recently have found (Limas, 1979) increased density of /8-adrenoreceptors in cardiac membranes from a model of mild hypertrophy induced by abdominal aortic constriction in rats. We now present evidence of enhanced phospholipid methylation in the hypertrophied myocardium which may be partly responsible for the changes in /?-adrenoreceptors.
Methods
Experiments were carried out on adult male Sprague-Dawley rats. Pressure overload was produced under ether anesthesia; following a midline abdominal incision, a 0.5-cm segment of the suprarenal abdominal aorta was isolated. A uniform degree of constriction around the aorta was produced by tying a 3-0 surgical silk tightly around the blunt end of a curved needle having an external diameter of 0.5 mm. The needle then was withdrawn from the ligature and the abdominal incision was closed. Sham-operated controls underwent the same procedure except that the silk was not tied. Simultaneous intraarterial pressures in the carotid and femoral arteries were measured, prior to killing the rats, with a Hewlett-Packard 1830c pressure transducer connected to a 7700 recorder. The pressure gradient averaged 47 ± 4 (mean ± SE) mm Hg; systolic pressure of operated rats averaged 152 ± 4 mm Hg.
Cardiac membranes were prepared as previously described (Limas and Limas, 1978) . Briefly, left ventricular tissue from six to eight animals was minced in four volumes of cold buffer containing 0.25 M sucrose-50 mM Tris-HCl (pH 7.4)-10 mM MgCla and was homogenized with a Polytron PT-20 at a setting of 3 for 15 seconds, twice. The supernatant was spun at 40,000 g for 30 minutes and the pellet was resuspended in 2.5 ml of 50 mM Tris-HCl (pH 7.4)-10 mM MgCl 2 .
Phospholipid methylation was assayed in a medium containing 125 mM TrisHCl (pH 9.2), 0.1 HIM S-adenosyl-L-[methyl-
3 H]-methionine [(New England Nuclear) specific activity, 13.6 Ci/mmol], 10 mM MgCl 2 , 0.1 HIM Na 2 -EDTA, and 0.1 mg membrane protein. The reactions were carried out at 37°C for varying lengths of time and were stopped by the addition of 3 ml chloroform:methanol:HCl (2:1:0.02, vol/vol) followed by 2 ml of 0.1 M KC1 in 50% ethanol. The tubes were shaken vigorously for 15 minutes and then centrifuged at 2000 g for 10 minutes. The aqueous phase was aspirated and the chloroform phase washed once more with 2 ml of 0.1 M KC1 in ethanol; 1 ml of the chloroform phase was transferred to a vial and, after the solvent had been evaporated to dryness at 80° C in an oven, 10 ml of Aquasol (New England Nuclear) were added for radioactivity counting.
For identification of the reaction products by thin layer chromatography, the chloroform phase was dried under nitrogen and dissolved in 50 jul of a chloroform :methanol (2:1, vol/vol) solution. Silica gel G plates were developed in three solvent systems: I. chloroform: methanol: 7 M urea, 60:35:5, by volume; II, chloroform: acetone: methanol: acetic acid: water, 5:2:1:1:0.5, by volume; III, chloroform: propionic acid:n-propyl alcohol:water, 2:2:3:1, by volume. Standards (phosphatidylcholine, monomethyl-, dimethyl-, and -phosphatidylethanolamine) were run concurrently in each system. After the solvent front had advanced 15 cm from the origin, the plates were dried, lipid spots were visualized with iodine and corresponding radioactivity was counted.
Identification of /S-adrenergic receptors was carried out as previously described (Limas and Limas, 1978) At the end of the incubation period, 100-/il aliquots were placed into 2 ml of ice-cold buffer and immediately passed through Whatman GF/C filters. The filters were washed with 10 ml of cold buffer, dried, added to 10 ml of Triton-toluene based scintillation fluid and counted. Nonspecific binding was determined in the presence of 10~5 M (±)propranolol. The relative purity of cardiac membranes was checked by determining the activities of Na + , K + -ATPase, 5'-nucleotidase, and cytochrome oxidase as previsouly described (Limas, 1977) . Nucleic acids were extracted by a modification of the Fleck and Munro (1962) procedure; RNA was determined by the orcinol method (Schmidt and Tannhauser, 1945) , DNA by the diphenylamine reaction (Burton, 1956 ), hydroxyproline according to Woessner (1961) and protein according to Lowry et al. (1951) . Adenylate cyclase was measured (Harden et al., 1976) in the presence of 0.15 mM GTP using [
3 H]ATP as the substrate. Cyclic AMP was separated using the method of Krishna et al. (1968) , with recovery of cyclic AMP determined by absorbance measurements. Statistical comparisons were made with the <-test for paired data; differences were considered significant if P < 0.05.
Results
Abdominal aortic constriction resulted in mild cardiac hypertrophy as indicated by increased heart:body weight ratio, LV weight, RNA and DNA content ( Table 1 ). The degree of cardiac enlargement increased with time and reached a plateau 2-3 weeks postoperatively. The yield of cardiac membranes was 1.68 ± 0.3 mg/g in hypertrophied and 1.21 ± 0.1 mg/g in control hearts (P < 0.01). The relative purity of the membrane preparations was similar in the two groups as judged by the distribution of marker enzymes (Na + , K + -ATPase, 5'-nucleotidase, cytochrome oxidase).
Phospholipid methylation by membrane fractions of both control and hypertrophied hearts was linear with time ( Fig. 1) up to 1 hour and significantly higher in rats with aortic constriction. Its dependence on S-adenosyl-methionine concentration in the assay medium is shown in Figure 2 ; a K m of 6.8 yM was calculated for both experimental groups. The nature of the methylation products was studied with thin layer chromatography (Fig. 3) Figure  4 . At 5 nM dihydroalprenolol, specific binding ac- counted for 65% to 75% of total binding. Although Kd values were essentially the same for both groups (2.4 ± 0.3 nM for controls and 2.2 ± 0.2 nM for hypertrophied), the maximal number of binding sites was significantly higher in the hypertrophied myocardium (139 ± 16 fmol/mg 2 weeks after aortic constriction vs. 94 ± 9 fmol/mg in controls, P < 0.01). The time course of changes in [ 3 H]dihydroalprenolol binding in response to aortic constriction is shown in Figure 5 ; significant increases first were noted 5 days postoperatively.
The effect of phospholipid methylation on [ 3 H]-dihydroalprenolol binding is shown in Figure 6 . There was a close correlation between the length of pre-incubation with S-adenosylmethionine and the 
01). Scatchard plots of the binding reaction showed unchanged Kd values after methylation (data not shown). The increase in [
3 H]dihydroalprenolol binding was proportional to the concentration of S-adenosylmethionine in the assay medium and was inhibited by S-adenosylhomocysteine (Table 2) ; other adenosylmethionine analogs, such as 5'-AMP and 1-methionine, were ineffective. In addition to y8-adrenergic receptor number , phos-20 30 Time (min) pholipid methylation enhanced isoproterenol-stimulated adenylate cyclase in both control and hypertrophied hearts (Table 3) ; basal and NaF-stimulated activities were not changed.
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FIGURE 6 Effect of phospholipid methylation on [ 3 HJdihydroalprenolol binding to cardiac membranes of control (A) and hypertrophied (A) hearts. Methylation was carried out at 37° C in the presence of 0.1 mM S-adenosyl-L-methionine and 2 mgprotein, as described in the text. Samples incubated in the absence of S-adenosyl-L-me-
Discussion
The results of this study strongly suggest a link between phospholipid methylation and number of /S-adrenergic receptors in both normal and hypertrophied myocardium. Phospholipid methylation recently has received considerable attention as a regulator of membrane structure and function (Usdin et al., 1979) . The synthesis of phosphatidylcholine from phosphatidylethanolamine through stepwise transfer of methyl groups from S-adenosylmethionine is catalyzed by specific methyltransferases. Two enzymes have been described by in adrenal and erythrocyte membranes. The first enzyme methylates phosphatidylethanolamine to phosphatidyl-iV-monomethylethanolamine, has a high affinity for S-adenosyl-L-methionine, and requires Mg 2 *. The second enzyme transfers two methyl groups to phosphatidyl-A^-monomethylethanolamine to form phosphatidylcholine via phosphatidyl-Af,iV'-dimethylethanolamine, has a low affinity for S-adenosylmethionine, and does not require Mg 2+ . These two enzymes, their substrates, and their products are distributed asymmetrically in the membrane; the first methyl transferase and phosphatidylethanolamine are localized on the cytoplasmic side, whereas the second transferase and phosphatidylcholine are on the exterior surface of the membrane. Such spatial segregation of the enzymes facilitates the rapid transfer of phospholipids across the membrane by successive methylation . It is not known, however, whether these separate enzyme activities are distributed universally in different tissues. Our findings for the myocardium, and those of Schneider and Vance (1979) for the liver, do not support the existence of distinct enzymes for the different methylation steps. This issue, however, will be resolved conclusively only after solubilization and characterization of the responsible enzymes. Enhanced phospholipid methylation in the hypertrophied myocardium may be viewed as an adaptive response peculiar to this model of cardiac hypertrophy or as a reflection of increased membrane synthesis during cell enlargement in response to aortic constriction. The first possibility can be examined only by comparing changes in phospholipid methylation in different models of cardiac hypertrophy. The second alternative is likely because of the changes in cell size that occur during the development of cardiac hypertrophy. Increased synthesis of cell membrane components is a necessary adaptation to cardiac hypertrophy because it ensures a normal cell surface to cytoplasmic volume ratio and a normal density of structures involved in excitation-contraction coupling (Page and McCallister, 1973) . Although both lipid and protein components are needed for membrane restructuring, studies on cardiac hypertrophy have focused primarily on the latter. There is a virtual absence of data concerning quantitative and qualitative changes in phospholipid metabolism during cardiac hypertrophy. This is surprising in view of the fact that phospholipids are important determinants of membrane fluidity and, as a result, the activities of several key enzymes such as sarcolemmal Na + , K + -ATPase (Palatini et al., 1972) , sarcoplasmic reticulum Ca 2+ -transport ATPase (Martonosi et al., 1971) , and adenylate cyclase (Engelhard et al., 1976; Limbird and Lefkowitz, 1976) . It is likely that variations in the lipid environment of such enzymes will have profound effects on calcium translocation mechanisms in the myocardium.
Enhanced phospholipid methylation in the hypertrophied myocardium may have functional implications beyond its role in membrane restructuring. Recent observations Hirata et al., 1979; Bhattacharya and Vonderhaar, 1979) suggest that translocation of methylated products across the cell membrane increases its fluidity and the coupling of /?-adrenoreceptors to adenylate cyclase and unmasks cryptic receptor sites. Increased numbers of myocardial /?-adrenergic receptors following phospholipid methylation may represent unmasking of latent receptors, perhaps secondary to changes in membrane fluidity. This may be expected to result in enhanced myocardial responsiveness to yS-adrenergic agonists provided that coupling to adenylate cyclase is preserved. The data in Table  3 indicate that numbers of increased ^-receptors after phospholipid methylation are indeed accompanied by an increase in catecholamine-sensitive adenylate cyclase in both normal and hypertrophied myocardium. Since neither basal nor fluoridestimulated adenylate cyclase was influenced, the data indicate that expression of hormone-sensitive adenylate cyclase is limited by the number of /?-adrenergic receptors. In addition, we have shown recently increased phosphorylation of cardiac sarcoplasmic reticulum and stimulated Ca 2+ transport in response to yS-adrenergic agonists following phospholipid methylation (unpublished observations). This provides additional indirect evidence that events distal to hormone binding also are stimulated by phospholipid methylation. Additional studies are needed to evaluate the possible role of phospholipid methylation in the control of calcium transport in the normal and hypertrophied heart. Increased numbers of ^-adrenergic receptors in this model of cardiac hypertrophy contrast with the reported decrease of these receptors in the myocardium of hypertensive rats (Limas and Limas, 1978; Woodcock et al., 1979) . The reasons for these differences are not known; they may relate to the degree of cardiac hypertrophy, its duration, and the influence of neurohumoral factors in the intact animal. It would be of interest to determine whether changes in phospholipid methylation are related to the variable alterations in numbers of /8-adrenoreceptors in different experimental models of cardiac hypertrophy.
